Abstract：Objective To examine the associations of arsenic and estrogen levels with the risk of papillary thyroid carcinoma, so as to provide insights into prevention of papillary thyroid carcinoma. Methods Totally 57 patients with papillary thyroid carcinoma admitted to two tertiary hospitals in Urumqi, Xinjiang Uygur Autonomous Region in 2018 were selected as the case group, while 57 subjects with normal thyroid functions during the same period were selected as the control group. Subjects' gender, age, ethnicity, occupation and medical history of thyroid disease were collected using questionnaire surveys. Serum dimethyl arsenic acid (DMA) and monomethyl arsenic acid (MMA) were determined using high-performance liquid chromatography (HPLC) coupled to hydride generation-atomic fluorescence spectrometry (HG-AFS), serum thyroid hormone (TSH) by radioimmunoassay, estradiol (E2) by enzyme-linked immunosorbent assay and estrogen receptor ERα and ERβ by western blotting. The associations of arsenic and estrogen levels with the risk of papillary thyroid carcinoma were evaluated using a multivariable logistic regression model. Results There were 16 males (28.07%) and 41 females (71.93%) in the case group, with a mean age of (42.63±11.01) years, and there were 21 males (36.84%) and 36 females (63.16%) in the control group, with a mean age of (40.89±11.30) years. There were no significant differences between the case and control groups in terms of age (χ2=0.373, P=0.542), gender (χ2=1.000, P=0.317) or ethnic composition (χ2=0.291, P=0.590). The serum levels of TSH [2.85 (1.61) vs. 2.45 (1.79) μmol/L], E2 [74.93 (120.44) vs. 61.60 (37.35) pmol/L], ERα [1.49 (1.13) vs. 0.70 (0.31)], ERβ [1.59 (0.55) vs. 0.72 (0.36)], DMA [116.02 (100.48) vs. 32.33 (56.06) μg/L] and MMA [56.92 (47.90) vs. 27.90 (24.99) μg/L] were all significantly higher in the case group than in the control group (Z=-2.414, -2.292, -4.923, -5.167, -5.448 and -4.019, all P<0.05). Multivariable logistic regression analysis showed DMA (OR=1.013, 95%CI: 1.003-1.024) and E2 levels (OR=1.020, 95%CI: 1.004-1.036) were associated with the risk of papillary thyroid carcinoma. Conclusion Increased arsenic load and elevated estradiol levels may be associated with the risk of papillary thyroid carcinoma.
[1] 任艳军,张铁威,刘庆敏,等.杭州市居民膳食模式与甲状腺癌的病例对照研究[J].预防医学,2020,32(11):1081-1085. REN Y J,ZHANG T W,LIU Q M,et al.Dietary patterns and thyroid cancer: a case-control studyin Hangzhou residents[J].Prev Med,2020,32(11):1081-1085. [2] 南琳,才仁,林海,等.乌鲁木齐某三甲医院2017年—2019年甲状腺癌临床特征及颈部淋巴结转移危险因素分析[J].中国病案,2021,22(4):54-57. NAN L,CAI R,LIN H,et al.Analysis of clinical characteristics of thyroid cancer and risk factors of cervical lymph node metastasis in a third-grade A hospital in Urumqi from 2017 to 2019[J].Chin Med Rec,2021,22(4):54-57. [3] 刘菊林,吴跃龙,李静,等.ER、EGFR在分化型甲状腺癌中的表达及其临床意义[J].现代生物医学进展,2013,13(5):908-910,927. LIU J L,WU Y L,LI J,et al.Expression and clinical significance of estrogen receptor and epidermal growth factor receptor in the differentiated thyroid carcinoma[J].Prog Mod Biomed,2013,13(5):908-910,927. [4] 郭宏宇,郝光,夏雅娟,等.慢性砷暴露对雌鼠血清雌二醇、孕酮水平的影响[J].卫生研究,2011,40(1):120-121. GUO H Y,HAO G,XIA Y J,et al.Effects on serum estadiol and progesterone of female mice exposed to arsenic chronically[J].J Hyg Res,2011,40(1):120-121. [5] AU W Y,LANG B H,FONG B M W,et al.Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia[J].Leuk Lymphoma,2014,55(5):1184-1185. [6] MOLIN M,ULVEN S M,DAHL L,et al.Arsenic in seafood is associated with increased thyroid-stimulating hormone(TSH)in healthy volunteers-a randomized controlled trial[J].J Trace Elem Med Biol,2017,44:1-7. [7] 王明军. 分化型甲状腺癌颈淋巴结转移超声特征及病理类型相关性分析[J].实用癌症杂志,2019,34(7):1154-1156. WANG M J.Ultrasound features of cervical lymph node metastasis in differentiated thyroid cancer and their correlation with pathological types[J].Pract J Cancer,2019,34(7):1154-1156. [8] 张北雁,刘庄,王颖.北京某高校教职工甲状腺疾病检出情况分析[J].当代医学,2017,23(9):57-58. ZHANG B Y,LIU Z,WANG Y.Analysis of thyroid diseases detected in teaching staff of a university in Beijing[J].Contemp Med,2017,23(9):57-58. [9] GONG G,BASOM J,MATTEVADA S,et al.Association of hypothyroidism with low-level arsenic exposure in rural West Texas[J].Environ Res,2015,138:154-160. [10] 孙洪杰. 砷的甲状腺毒性及对甲状腺内分泌系统的影响[D].南京:南京大学,2016. SUN H J.Thyroid toxicity of arsenic and its effect on thyroid endocrine system[D].Nanjing:Nanjing University,2016. [11] HAYMART M R, REPPLINGER D J, LEVERSON G E,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-814. [12] HUANG Y,DONG W,LI J,et al.Differential expression patterns and clinical significance of estrogen receptor-alpha and beta in papillary thyroid carcinoma[J/OL].BMC Cancer,2014,14(2014-05-29)[2022-03-13].https://doi.org/10.1186/1471-2407-14-383. [13] 李兴佳,徐书杭,刘超.雌激素及其受体与甲状腺癌的关系[J].国际内分泌代谢杂志,2016,36(4):273-276. LI X J,XU S H,LIU C.Relationship between estrogen,its receptors and thyroid cancer[J].Int J Endocrinol Metab,2016,36(4):273-276. [14] ZENG Q,CHEN G G,VLANTIS A C,et al.Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway[J].Cell Prolif,2007,40(6):921-935. [15] LIU J,CHEN G,MENG X Y,et al.Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms[J].Pathol Res Pract,2014,210(12):830-835. [16] 金东岭,李联祥,刘现军,等.雌激素受体ERα、ERβ亚型与Ki-67在不同甲状腺病变组织中的表达及其意义[J].解放军医学杂志,2008,33(9):1109-1112. JIN D L,LI L X,LIU X J,et al.Expression and significance of estrogen receptor subsets ERα,ERβ and Ki-67 in tissues of different thyroid diseases[J].Med J Chin PLA,2008,33(9):1109-1112. [17] 李宏昀,马晓薇,江志红,等.大鼠砷暴露致雌激素效应及对甲状腺功能的影响[J].实用预防医学,2021,28(12):1415-1420. LI H Y,MA X W,JIANG Z H,et al.Estrogenic effect of arsenic exposure and its effect on thyroid function in rats[J].Pract Prev Med,2021,28(12):1415-1420.
